文献速递心脑血管急症重症综合管理与镇静镇痛

预测重型创伤性脑损伤后7-10年临床结局:IMPACT实验室模型与脑脊液UCH-L1、MAP-2的预后价值探索

Predicting Clinical Outcomes 7-10 Years after Severe Traumatic Brain Injury: Exploring the Prognostic Utility of the IMPACT Lab Model and Cerebrospinal Fluid UCH-L1 and MAP-2.
PubMed 文献 · Neurocrit Care · 2022-03-01
一句话结论初步观察性研究提示,IMPACT实验室模型及联合脑脊液UCH-L1、MAP-2可能用于预测重型TBI后7-10年的远期功能与认知结局。

该初步观察性预后研究评估IMPACT实验室模型对重型TBI后7-10年整体与认知结局的预测价值,并探讨急性期脑脊液UCH-L1、MAP-2的附加预测作用。59名参与者纳入远期整体结局分析(其中41人未存活),18名存活至7-10年者评估日常认知功能,其中10人完成电话数字广度测试。IMPACT实验室模型区分7-10年结局的AUC为0.80;风险评分越高,远期病残程度越重(β=0.488,p=0.000)、认知独立性越低(β=-0.515,p=0.034)。急性期UCH-L1升高预测认知活动独立性较差(β=0.286,p=0.048);联合IMPACT评分、UCH-L1和MAP-2的模型可解释认知表现89.6%的变异(p=0.008),UCH-L1越高认知表现越差(β=-0.496,p=0.029),MAP-2越高认知保护效应越强(β=0.679,p=0.010)。作者认为结果虽属初步,但提示现有预后模型(含脑脊液标志物)可能用于预测重型TBI多年后结局,仍需继续研究早期预测因子。

要点

  • IMPACT实验室模型区分重型TBI后7-10年有利与不利结局的AUC为0.80。
  • IMPACT实验室模型风险评分越高,远期病残程度越重(β=0.488,p=0.000),认知独立性越低(β=-0.515,p=0.034)。
  • 急性期脑脊液UCH-L1升高预测远期日常认知活动独立性较差(β=0.286,p=0.048)。
  • 联合IMPACT评分、UCH-L1和MAP-2的模型解释远期认知表现89.6%的变异(p=0.008)。
  • 急性期UCH-L1越高远期认知表现越差(β=-0.496,p=0.029),MAP-2越高认知保护效应越强(β=0.679,p=0.010)。

适用人群与场景

  • 重型创伤性脑损伤患者,纳入59名参与者进行7-10年远期整体结局评估,其中41人未存活至评估。
  • 18名存活至伤后7-10年的参与者完成日常认知功能评估,其中10人完成电话数字广度测试。

研究设计与关键结果

  • 研究类型为初步观察性预后研究,评估IMPACT实验室模型对重型TBI后7-10年整体与认知结局的预测价值及脑脊液UCH-L1、MAP-2的附加作用。
  • 59名参与者中41人未存活,采用格拉斯哥结局扩展量表与残疾评定量表评估远期整体结局。
  • IMPACT实验室模型区分有利与不利7-10年结局的受试者工作特征曲线下面积为0.80。
  • IMPACT实验室模型风险评分越高,远期病残程度越重(β=0.488,p=0.000),认知独立性越低(β=-0.515,p=0.034)。
  • 急性期脑脊液UCH-L1升高预测远期日常认知活动独立性较差(β=0.286,p=0.048)。
  • 联合IMPACT评分、UCH-L1和MAP-2的模型解释远期认知表现89.6%的变异(p=0.008)。
  • 急性期UCH-L1越高远期认知表现越差(β=-0.496,p=0.029),MAP-2越高认知保护效应越强(β=0.679,p=0.010)。

证据类型、等级与局限

  • 证据类型:初步观察性预后研究。
  • 作者指出结果为初步性,仍需继续研究早期预测因子以确定可能影响远期功能与认知结局的临床试验靶点。

对床旁实践的改变

  • 作者认为,现有预后模型(包括纳入脑脊液标志物的模型)可能用于预测重型TBI多年后的结局。
  • 作者指出仍需继续研究早期预测因子,以确定可能影响远期功能与认知结局的临床试验靶点。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: Severe traumatic brain injury (TBI) is a major contributor to disability and mortality in the industrialized world. Outcomes of severe TBI are profoundly heterogeneous, complicating outcome prognostication. Several prognostic models have been validated for acute prediction of 6-month global outcomes following TBI (e.g., morbidity/mortality). In this preliminary observational prognostic study, we assess the utility of the International Mission on Prognosis and Analysis of Clinical Trials in TBI (IMPACT) Lab model in predicting longer term global and cognitive outcomes (7-10 years post injury) and the extent to which cerebrospinal fluid (CSF) biomarkers enhance outcome prediction.

METHODS: Very long-term global outcome was assessed in a total of 59 participants (41 of whom did not survive their injuries) using the Glasgow Outcome Scale-Extended and Disability Rating Scale. More detailed outcome information regarding cognitive functioning in daily life was collected from 18 participants surviving to 7-10 years post injury using the Cognitive Subscale of the Functional Independence Measure. A subset (n = 10) of these participants also completed performance-based cognitive testing (Digit Span Test) by telephone. The IMPACT lab model was applied to determine its prognostic value in relation to very long-term outcomes as well as the additive effects of acute CSF ubiquitin C-terminal hydrolase-L1 (UCH-L1) and microtubule associated protein 2 (MAP-2) concentrations.

RESULTS: The IMPACT lab model discriminated favorable versus unfavorable 7- to 10-year outcome with an area under the receiver operating characteristic curve of 0.80. Higher IMPACT lab model risk scores predicted greater extent of very long-term morbidity (β = 0.488 p = 0.000) as well as reduced cognitive independence (β = - 0.515, p = 0.034). Acute elevations in UCH-L1 levels were also predictive of lesser independence in cognitive activities in daily life at very long-term follow-up (β = 0.286, p = 0.048). Addition of two CSF biomarkers significantly improved prediction of very long-term neuropsychological performance among survivors, with the overall model (including IMPACT lab score, UCH-L1, and MAP-2) explaining 89.6% of variance in cognitive performance 7-10 years post injury (p = 0.008). Higher acute UCH-L1 concentrations were predictive of poorer cognitive performance (β = - 0.496, p = 0.029), whereas higher acute MAP-2 concentrations demonstrated a strong cognitive protective effect (β = 0.679, p = 0.010).

CONCLUSIONS: Although preliminary, results suggest that existing prognostic models, including models with incorporation of CSF markers, may be applied to predict outcome of severe TBI years after injury. Continued research is needed examining early predictors of longer-term outcomes following TBI to identify potential targets for clinical trials that could impact long-ranging functional and cognitive outcomes.

来源:Neurocrit Care,查看原文。版权归原作者所有。

参考来源

  1. Svingos AM, Robicsek SA, Hayes RL, et al. Predicting Clinical Outcomes 7-10 Years after Severe Traumatic Brain Injury: Exploring the Prognostic Utility of the IMPACT Lab Model and Cerebrospinal Fluid UCH-L1 and MAP-2. Neurocrit Care. 2022. PMID: 35229233. doi:10.1007/s12028-022-01461-y

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。